2012 - Transplantomics and Biomarkers in Transplantation


Omics and the Big Questions in Transplantation

9.4 - Integrating Evidence-Based Best Practice, Health Services and Outcomes Research, and Genomic Biomarkers – the Singularity in US Healthcare – can we afford it?

Presenter: Michael I., Abecassis, Chicago, IL, USA
Authors: Michael I. Abecassis


8-4_Abecassis

You must be logged in to view recordings

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi